Viral Reactivation and Autism Regression: What Parents Need to Know
Your child was developing. Talking, connecting, making progress. Then something shifted.
Maybe it was sudden. Maybe it crept up over weeks or months until you looked back and realised how much ground had been lost. Either way, you know something changed.
When a child's development changes, there is always a biological reason. Always. The brain does not just decide to go backwards. Something shifted in the immune system, the gut, the nervous system, the metabolism, or the environmental load. Usually several of these at once.
That is what we see in clinic, consistently, across thirteen years and over three and a half thousand families.
WHY VIRUSES ARE PART OF THE CONVERSATION
Recently I have been asked about Dr Ken Alibek and his proposal that viral reactivation may explain regression in a subset of children.
The idea is straightforward. Certain viruses, herpesviruses in particular, remain dormant in the body after the initial infection. Under the right conditions they reactivate, triggering immune signalling that disrupts brain function.
He is not claiming autism is caused by viruses. He is describing a specific subgroup - children who regress, whose symptoms fluctuate, and whose presentation tracks with immune changes.
That subgroup is real. We see these children all the time. The science behind it is sound. Viruses persist in the body. Immune signalling affects the brain. Inflammation alters behaviour, cognition, and sleep.
For some children, his approach produces genuine improvement. I do not dispute that.
But there is a gap between what Alibek is actually proposing and what is landing with families. He describes a subset. By the time that message reaches parents through social media and online groups, it has often become 'viruses cause regression,' and families are understandably jumping straight to treatment without knowing whether their child's presentation actually fits. That concerns me.
WHAT WE SEE WHEN WE LOOK PROPERLY
When you take a thorough history from families, the clues are often there. A parent who had glandular fever. Recurrent shingles in close relatives. A child who caught every virus going in the first couple of years. Clear deterioration after illness or physiological stress.
When we run lymphocyte subset analysis and interpret serology in context, patterns emerge. Not one dramatic abnormality. A constellation.
But the viral picture is almost never the whole story.
THE BIGGER PICTURE
In practice, immune dysregulation sits alongside gut disruption, and the gut is feeding the immune picture. The nervous system is stuck in overdrive, amplifying inflammation and wrecking sleep. Poor sleep erodes metabolic resilience. Reduced metabolic capacity makes it harder for the body to clear infections, toxins, and mould. These systems knock into each other constantly. You cannot understand the pattern by looking at one piece.
Many parents report that their child improves during a fever - more eye contact, more language, more connection. That is one of the most important clues in this entire picture. It tells us that when immune signalling shifts, brain function shifts with it.
So the question becomes bigger than "which virus is active." If a change in immune activity can temporarily restore function, what is driving the immune environment that is holding this child back? That is the question we need to be asking, and it is why looking at viruses alone will never give you the full answer.
WHY ONE-PROTOCOL THINKING WORRIES ME
Alibek's treatment model is aggressive. Antivirals, antimicrobials, anti-inflammatories, mast cell agents, gut therapies, mitochondrial support - often all at once from the start. The philosophy is maximalist. Hit every pathway. Hit it hard. Hit it fast.
I understand why that appeals. When your child is struggling, you want someone who will do something. A confident clinician with a clear protocol feels like a lifeline.
But confidence is not evidence. And a protocol designed for a specific subset does not automatically translate to every child, no matter how promising it sounds.
Here is the clinical problem. When you introduce multiple biologically active treatments simultaneously in a child who is already fragile, you lose all your information. If the child improves, you do not know what helped. If they destabilise, you do not know what triggered it. It is like changing your child's entire diet in one go - you might see a result, but you have no idea which change made the difference. And if things go wrong, you are stuck.
These are sensitive children. Their systems are already unstable. Piling in with multiple strong interventions can amplify that instability rather than calm it. These children come through our door every week.
HOW WE WORK
We have been working with immune-driven presentations for thirteen years, well before viral reactivation entered the mainstream conversation. We incorporated microimmunotherapy, tools designed to gently regulate immune signalling rather than suppress it, nearly seven years ago because we kept seeing children whose neurological symptoms moved in step with their immune activity. We needed precision, not force.
We work across five interconnected domains: immune balance, gut signalling, nervous system stability, metabolic resilience, and environmental load. Not because we want to overcomplicate things, but because that is how these children's biology actually works.
A child whose nervous system is in overdrive will not respond well to aggressive immune treatment. A child carrying significant mould or toxic burden will keep relapsing no matter how well you address the immune picture. A child whose metabolic systems are depleted will not have the capacity to process multiple interventions. You have to understand how the problems connect before you can work out the right order to fix them.
We stabilise first. We observe. We intervene one step at a time so that each move gives us real information. It is slower. But it is how you find out what is actually driving that child's symptoms rather than guessing and hoping for the best.
DO NOT BE FOOLED BY A POSITIVE VIRAL TEST
This causes enormous confusion and I see it constantly.
There are two main types of viral antibody that show up on a test. IgG means your child was exposed to that virus at some point and their immune system remembers it. That is normal. That is what immune memory is. Most adults are IgG positive for EBV, HHV-6, and CMV. It does not mean the virus is active.
IgM is different. IgM antibodies appear during a recent or active infection. If IgM is raised, that is worth paying attention to. But even IgM has caveats - it can sometimes stay elevated for months after an infection has resolved, and in some children with immune dysregulation, IgM patterns can be unreliable.
I see families arrive in clinic convinced their child has active EBV or HHV-6 because someone ran an antibody panel and the IgG came back positive. That is not a diagnosis. That is immune memory doing exactly what it should.
If viral reactivation were genuinely driving symptoms, you would expect to see a pattern building over time across multiple markers, not just one raised result on one test. It is the pattern that matters, not a single snapshot.
WHAT PARENTS NEED TO HEAR
If your child has regressed, whether it happened in days or unfolded over months, this is biological. Something changed in their system. It can be identified and it can be worked with.
Viral reactivation may be part of your child's picture. For some children it is significant. But for most, it sits alongside other drivers - gut, nervous system, metabolic, environmental - and the best outcomes come from understanding how those pieces interact in your particular child.
There is no single protocol that fits every child in this group, because these children are not simple. The ones who do best are the ones whose treatment is built around their individual biology, sequenced so that each step makes the next one more likely to succeed, and adjusted as we learn what their system actually needs.
That is not the fastest route. But it is how you get progress that lasts.
IMPORTANT
This information is for educational purposes only and is not a substitute for professional medical advice diagnosis or treatment. Always consult with medical doctors or qualified functional medicine practitioners before introducing any new supplement, test, or intervention.
Concerned about your child's health? We are happy to talk.
REFERENCES
Grzadzinski, R., Lord, C., Sanders, S.J., Werling, D. and Bal, V.H., 2018. Children with autism spectrum disorder who improve with fever: Insights from the Simons Simplex Collection. Autism Research, 11(1), pp.175-184.
Reed, M.D., Yim, Y.S., Wimmer, R.D., Kim, H., Ryu, C., Welch, G.M., Andina, M., King, H.O., Waisman, A., Halassa, M.M., Huh, J.R. and Choi, G.B., 2020. IL-17a promotes sociability in mouse models of neurodevelopmental disorders. Nature, 577(7789), pp.249-253.
Naviaux, R.K., 2014. Metabolic features of the cell danger response. Mitochondrion, 16, pp.7-17.
Dantzer, R., O'Connor, J.C., Freund, G.G., Johnson, R.W. and Kelley, K.W., 2008. From inflammation to sickness and depression: when the immune system subjugates the brain. Nature Reviews Neuroscience, 9(1), pp.46-56.
Cohly, H.H. Pand Panja, A., 2005. Immunological findings in autism. International Review of Neurobiology, 71, pp.317-341.
Mead, J. and Ashwood, P., 2015. Evidence supporting an altered immune response in ASD. Immunology Letters, 163(1), pp.49-55.
Hornig, M., 2013. The role of microbes and autoimmunity in the pathogenesis of neuropsychiatric illness. Current Opinion in Rheumatology, 25(4), pp.488-795.
Herbert, M., 2012. The Autism Revolution: Whole-Body Strategies for Making Life All It Can Be. Harvard Health Publications/Ballantine Books.